These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1418912)

  • 1. Progress in the treatment of childhood leukaemias.
    Lie SO; Gustafsson G
    Ann Med; 1992 Oct; 24(5):319-23. PubMed ID: 1418912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood non-Hodgkin's lymphoma in the five Nordic countries. A five-year population-based study from the Nordic Society of Pediatric Hematology and Oncology.
    Márky I; Schmiegelow K; Perkkiö M; Jónsson OG; Storm-Mathiesen I; Gustafsson G; Kreuger A; Langmark F
    J Pediatr Hematol Oncol; 1995 May; 17(2):163-6. PubMed ID: 7749767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birth weight and risk for childhood leukemia in Denmark, Sweden, Norway, and Iceland.
    Hjalgrim LL; Rostgaard K; Hjalgrim H; Westergaard T; Thomassen H; Forestier E; Gustafsson G; Kristinsson J; Melbye M; Schmiegelow K
    J Natl Cancer Inst; 2004 Oct; 96(20):1549-56. PubMed ID: 15494605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age- and sex-specific incidence of childhood leukemia by immunophenotype in the Nordic countries.
    Hjalgrim LL; Rostgaard K; Schmiegelow K; Söderhäll S; Kolmannskog S; Vettenranta K; Kristinsson J; Clausen N; Melbye M; Hjalgrim H; Gustafsson G
    J Natl Cancer Inst; 2003 Oct; 95(20):1539-44. PubMed ID: 14559876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia: a retrospective case-control study in the Nordic countries. Nordic Society for Pediatric Hematology and Oncology (NOPHO).
    Saarinen UM; Mellander L; Nysom K; Ringden O; Schroeder H; Glomstein A; Gustafsson G
    Bone Marrow Transplant; 1996 Mar; 17(3):357-63. PubMed ID: 8704687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
    Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
    Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO).
    Gustafsson G; Kreuger A; Clausen N; Garwicz S; Kristinsson J; Lie SO; Moe PJ; Perkkiö M; Yssing M; Saarinen-Pihkala UM
    Acta Paediatr; 1998 Nov; 87(11):1151-61. PubMed ID: 9846917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study Group.
    Forestier E; Johansson B; Gustafsson G; Borgström G; Kerndrup G; Johannsson J; Heim S
    Br J Haematol; 2000 Jul; 110(1):147-53. PubMed ID: 10930992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal growth and childhood cancer: a population-based study.
    Bjørge T; Sørensen HT; Grotmol T; Engeland A; Stephansson O; Gissler M; Tretli S; Troisi R
    Pediatrics; 2013 Nov; 132(5):e1265-75. PubMed ID: 24167169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).
    Gustafsson G; Schmiegelow K; Forestier E; Clausen N; Glomstein A; Jonmundsson G; Mellander L; Mäkipernaa A; Nygaard R; Saarinen-Pihkala UM
    Leukemia; 2000 Dec; 14(12):2267-75. PubMed ID: 11187918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Childhood acute lymphoblastic leukemia in Norway 1992-2000].
    Kolmannskog S; Flaegstad T; Helgestad J; Hellebostad M; Zeller B; Glomstein A
    Tidsskr Nor Laegeforen; 2007 May; 127(11):1493-5. PubMed ID: 17551551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries.
    Garwicz S; Anderson H; Olsen JH; Døllner H; Hertz H; Jonmundsson G; Langmark F; Lanning M; Möller T; Sankila R; Tulinius H
    Int J Cancer; 2000 Nov; 88(4):672-8. PubMed ID: 11058888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute leukaemias.
    Stevens RF
    Baillieres Clin Haematol; 1991 Apr; 4(2):429-58. PubMed ID: 1912666
    [No Abstract]   [Full Text] [Related]  

  • 14. Time trends in the incidence of acute lymphoblastic leukemia among children 1976-2002: a population-based Nordic study.
    Svendsen AL; Feychting M; Klaeboe L; Langmark F; Schüz J
    J Pediatr; 2007 Nov; 151(5):548-50. PubMed ID: 17961705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection mode of childhood acute lymphoblastic leukaemia relapse and its effect on survival: a Nordic population-based cohort study.
    Jensen KS; Oskarsson T; Lähteenmäki PM; Flaegstad T; Schmiegelow K; Vedsted P; Albertsen BK; Schrøder H;
    Br J Haematol; 2021 Aug; 194(4):734-744. PubMed ID: 34041748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.
    Andersen MK; Autio K; Barbany G; Borgström G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Johansson B; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E
    Br J Haematol; 2011 Oct; 155(2):235-43. PubMed ID: 21902680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer in the Nordic countries, 1981-86. A joint publication of the five Nordic Cancer Registries.
    Tulinius H; Storm HH; Pukkala E; Andersen A; Ericsson J
    APMIS Suppl; 1992; 31():1-194. PubMed ID: 1301768
    [No Abstract]   [Full Text] [Related]  

  • 18. Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries.
    Hakulinen T; Andersen A; Malker B; Pukkala E; Schou G; Tulinius H
    Acta Pathol Microbiol Immunol Scand Suppl; 1986; 288():1-151. PubMed ID: 3465196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic Cancer Registries.
    Engeland A; Haldorsen T; Tretli S; Hakulinen T; Hörte LG; Luostarinen T; Schou G; Sigvaldason H; Storm HH; Tulinius H
    APMIS Suppl; 1995; 49():1-161. PubMed ID: 7702878
    [No Abstract]   [Full Text] [Related]  

  • 20. Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol.
    Barbany G; Andersen MK; Autio K; Borgström G; Franco LC; Golovleva I; Heim S; Heinonen K; Hovland R; Johansson B; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E; ; ;
    Leuk Res; 2012 Jul; 36(7):936-8. PubMed ID: 22521551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.